March 18, 2021
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer has retained The Chase Group to identify a Head of US Business Development in the Boston area to build on the company’s global growth strategy. This new role will require an entrepreneurial approach fueled by an intense desire to establish a presence in the US. The Head of Business Development will be challenged to grow the company by promoting the robust portfolio of products aimed at providing innovative solutions for unmet medical needs in neurological disorders and pulmonary vascular and interstitial lung diseases. The Ferrer leadership team is committed to increasing its focus on business development in the US, providing the successful candidate a unique opportunity to work in a collaborative and passionate environment as they work to build and shape the US organization of Ferrer. As retained strategic partners, The Chase Group understands the impact this critical new hire will have on the future success of Ferrer and will utilize knowledge, experience, and a vast network to identify and secure the high caliber talent required for this key leadership role. To learn more about The Chase Group’s proven approach to retained executive search, email karen@chasegroup.com.
